The important difference between AstraZeneca’s relationship with the UK and its relationship with the EU – and the reason it has fallen behind schedule on around 50m vaccine doses promised to the bloc – is that the UK agreed its deal with AstraZeneca a full three months before the EU did.

Is the EU to blame for AstraZeneca’s vaccine shortage?

Comments
Don't miss out
Join the conversation with other Spectator readers. Subscribe to leave a comment.
UNLOCK ACCESSAlready a subscriber? Log in